Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Mode of action of Oxigene's CA4P supported by preclinical data

July 2, 2001

Matrix commences new phase II IntraDose study for primary liver cancer

July 2, 2001

TLK-286 enters phase II trial for non-small cell lung cancer

July 2, 2001

New data for Gleevec show increase in CML response rates over time

June 29, 2001

Immunomedics and IBC report on bispecific antibody studies

June 29, 2001

Cytokinetics and GlaxoSmithKline establish cancer drug discovery alliance

June 28, 2001

GenVec and Varian Medical extend collaborative agreement for treatment of cancer

June 28, 2001

Licensing opportunity from NIH: methods of treating cancer, diabetes based on adrenomedullin

June 28, 2001

Positive phase I results reported for Active Biotech's TTS

June 27, 2001

Novuspharma's IND for BBR-2778 accepted by FDA

June 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...